AprilWangArmstrongMDMPH

Dermatology • Los Angeles, CA

Chief of Dermatology at UCLA, Professor of Medicine

Join to view full profile

Dr. Armstrong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Armstrong's full profile

Already have an account?

Office
911 Broxton Ave
3rd floor
Los Angeles, CA 90024
Phone+1 800-872-2273

Fax+1 323-442-5953
Is this information wrong?

Education & Training

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2005 - 2008
Massachusetts General HospitalInternship, Internal Medicine, 2004 - 2005
Harvard Medical SchoolClass of 2004
Harvard School of Public HealthClinical Effectiveness Program
Harvard School of Public HealthM.P.H.

Certifications & Licensure

CA State Medical License 2008 - 2026
CO State Medical License 2013 - 2017
MA State Medical License 2004 - 2008
American Board of Dermatology Dermatology
National Board of Medical ExaminersDiplomate

Awards, Honors, & Recognition

Presidential Citation for Contributions to Psoriasis Research and Clinical Care American Academy of Dermatology, 2016
Young Dermatologist International Achievement Award International League of Dermatological Societies (ILDS)., 2015
Improving Healthcare Systems [SC14-1403-12419], Principal Investigator. Patient-Centered Outcomes Research Institute (PCORI), 2014
Faculty Mentor Award in Recognition of Excellence in Mentoring Students for the Medical Student Research Fellowship University of California Davis School of Medicine, 2010, 2012-2013
Recognition Award for Contributions to the Standards and Guidelines Committee Teledermatology Special Interest Group, American Telemedicine Association, 2012
First Prize in Pharmacology British Medical Association Medical Book Award, Associate Editor., 2012
Presidential Citation for Contributions to Teledermatology. American Academy of Dermatology, 2011
Patient-Directed Investigation Award Dermatology Foundation, Principal Investigator, 2010
Faculty Mentor Award in Recognition of Excellence in Mentoring NIH T32 Clinical Research Trainees University of California Davis School of Medicine., 2010
Academic Dermatology Leader Academic Dermatology Leadership Program (ADLP), American Academy of Dermatology., 2010
Editor’s Choice Award for Manuscript British Journal of Dermatology, 2010
Agency for Healthcare Quality and Research (AHRQ) K08 Mentored Clinical Scientist Research Career Development Award [PAR-09-085], Principal Investigator. 2009
NIH K12 Mentored Career Development Program [National Institutes of Health RR 024144], Clinical and Translational Science Center University of California Davis Principal Investigator, 2009
Dermatology Foundation Career Development Award, Principal Investigator. 2009
Research Award to examine access to dermatology using connected health technology Women’s Dermatologic Society, Principal Investigator, 2009
Research Award to examine store-and-forward teledermatology technology California HealthCare Foundation, Principal Investigator., 2009
NIAMS LRP Award NIAMS National Institutes of Health, Principal Investigator., 2009
First-Place Resident Research Award, "Text-Message Reminders Improve Medication Adherence to Sunscreen: A Randomized, Controlled Trial Using Electronic Monitoring," Department of Dermatology, Massachusetts General Hospital Clinical Research Conference., 2008
Resident Award (First Place) Teledermatology Special Interest Group, American Telemedicine Association, 2006, 2008
Connetics Clinical Research Fellowship for Improving Access to Dermatologic Care Center for Connected Health, Massachusetts General Hospital, Harvard Medical School, Principal Investigator, 2007
Recognition for Outstanding Poster 21st World Congress of Dermatology, Buenos Aires, Argentina., 2007
Dermatology Resident Scholarship to the 21st World Congress of Dermatology in Buenos Aires, Argentina American Academy of Dermatology, 2007
Dermatology Departmental Research Award, "A Secure, Fast, and Easily Accessible Dermatology Online Image Solution," Massachusetts General Hospital Clinical Research Conference., 2007
Information Technology Innovation Award: Academic Research grant to study medication adherence Information Systems Research Council, Partners HealthCare, Partners HealthCare, Co-Principal Investigator., 2007
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Comparison Of Video-based Versus Written Patient Education on Sunscreen Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Comparison of Video-Based Versus Written Patient Education on Melanoma Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis Start of enrollment: 2009 Sep 01
Completed
Not Applicable
Use of Portable Technology in Patient Education of Shave/Punch Biopsies Start of enrollment: 2009 Jul 01
Completed
Not Applicable
Vascular Inflammation in Psoriasis Trial (The VIP Trial) Start of enrollment: 2012 Jul 01
Completed
Phase 4
Vascular Inflammation in Psoriasis - Extension Study Start of enrollment: 2013 Apr 01
Completed
Phase 4
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials.
Ayumi Yoshizaki, Paolo Gisondi, Balint Szilagyi, Luke Peterson, Dirk de Cuyper, Nancy Cross, Owen Davies, Alice B Gottlieb, Mark Lebwohl, Joseph F Merola, Bruce Strobe...> ;Journal of the American Academy of Dermatology. 2024 Apr 6
An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis.
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, Audrey Hao, Rebecca K Yamamoto, Hannah C Tolson, Sara N Bilimoria, Danielle K Yee, April W Armstrong> ;Cells. 2024 Mar 28
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinica...
Alvaro González-Cantero, Guilherme Muzy, William N Malatestinic, Anastasia Lampropoulou, Sophia Kyoungah See, Can Mert, April Armstrong, Saakshi Khattri, Meghan Feely,...> ;Dermatology and Therapy. 2024 Mar 23
Executive Summary: From the Medical Board of the National Psoriasis Foundation: Perioperative management of immunomodulatory agents in patients with psoriasis and psor...
Warren A James, Angela L Rosenberg, Jashin J Wu, Sylvia Hsu, April Armstrong, Elizabeth B Wallace, Lara Wine Lee, Joseph Merola, Sergio Schwartzman, Dafna Gladman, Cli...> ;Journal of the American Academy of Dermatology. 2024 Mar 16
Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psori...
Julia-Tatjana Maul, Johannes A Didaskalu, Fernando Valenzuela, Ricardo Romiti, Hannah Peterson, Farah Novoa, Hazel H Oon, Min Zheng, Jashin J Wu, Jacob P Thyssen, Alex...> ;Acta Dermato-Venereologica. 2024 Mar 12
Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2).
Bruce Strober, Andrew Blauvelt, Richard B Warren, Kim A Papp, April W Armstrong, Kenneth B Gordon, Akimichi Morita, Andrew F Alexis, Mark Lebwohl, Peter Foley, Renata ...> ;Journal of the European Academy of Dermatology and Venereology. 2024 Mar 7
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials.
Andrew Blauvelt, April Armstrong, Joseph F Merola, Bruce Strober, Dirk de Cuyper, Luke Peterson, Owen Davies, Jeffrey L Stark, Mark Lebwohl> ;Journal of the American Academy of Dermatology. 2024 Mar 4
Comparing Cosmetic Outcomes of Straight-Line Versus W-Plasty Techniques for Linear Postauricular Wound Closure: A Randomized Evaluator Blind Split-Scar Trial.
Mehrnaz Mehrzad, Alison S Kang, April W Armstrong, Daniel B Eisen> ;Dermatologic Surgery. 2024 Feb 28
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
Brusselle, G., Sun, L., Siu, K., Wu, W., Corren, J., Szefler, S., Sher, E., Korenblat, P., Soong, W., Hanania, N., Berman, G., Zitnik, R., Natalie, C., Lio, P., Armstr...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Feb 14
Depression screening for psoriasis in the United States: A population-based study.
Margaret Y Huang, Paige Kingston, Hannah Peterson, Danielle Yee, Kathryn Lee, Edwin Korouri, Rosario Agüero, April W Armstrong> ;Journal of the European Academy of Dermatology and Venereology. 2024 Feb 12
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the Nat...
Chat, V., Ellebrecht, C., Kingston, P., Gondo, G., Bell, S., Cordoro, K., Desai, S., Duffin, K., Feldman, S., Garg, A., Gelfand, J., Gladman, D., Green, L., Gudjonsson...> ;Journal of the American Academy of Dermatology. 2024 Feb 7
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review.
Lourdes M Pérez-Chada, Zachary H Hopkins, Deepak M W Balak, Sarem Rashid, Andrew Creadore, Brian Chu, Camila Villa, Michael J Woodbury, April W Armstrong, Vibeke Stran...> ;JAMA Dermatology. 2024 Jan 24
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey.
Jayade, S., Rege, S., Joshi, N., Patel, V., Kalirai, S., Wolin, D., Boyle, K., Patel, D., Seigel, L., Armstrong, A.> ;Dermatology and Therapy. 2024 Feb 1
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestation...
Strober, B., Bachelez, H., Gooderham, M., Menter, A., Strohal, R., Chen, M., Wu, T., Zhan, T., Photowala, H., Crowley, J., Elewski, B., Armstrong, A.> ;Journal of the European Academy of Dermatology and Venereology. 2024 Jan 5
A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.
Song, W., Garshick, M., Barbieri, J., Shin, D., Báez, S., Papadopoulos, M., Neopaney, A., Fitzsimmons, R., Kalb, R., Mease, P., Craig, E., Koplin, J., Takeshita, J., C...> ;The Journal of Investigative Dermatology. 2024 Jan 4
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial.
Papp, K., Strober, B., Zhuo, J., Becker, B., Zhong, Y., Beaumont, J., Pham, T., Kisa, R., Napoli, A., Banerjee, S., Gordon, K., Armstrong, A.> ;JAMA Dermatology. 2024 Feb 1
Trends in Patch-Test Positivity to Methylchloroisothiazolinone and Methylisothiazolinone Based on Regulatory Status: A Systematic Review.
Kingston, P., Khan, S., Chan, J., Pourali, S., Armstrong, A., DeLeo, V., Adler, B.> ;Dermatitis. 2023 Dec 4
Assessing the Quality, Comprehensiveness, and Readability of Online Patient Health Resources About Psoriasis in Skin of Color.
Danielle Yee, Kathryn Lee, Margaret Y Huang, Paige Kingston, Edwin Korouri, Hannah Peterson, April W Armstrong> ;The Journal of Clinical and Aesthetic Dermatology. 2023 Dec 1
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Derm...
Jonathan I Silverberg, April Armstrong, Andrew Blauvelt, Kristian Reich> ;American Journal of Clinical Dermatology. 2024 Jan 1
Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne.
Ali Shields, April W Armstrong, Manraj N Kaur, Alison Layton, Diane Thiboutot, Jerry Tan, John S Barbieri> ;JAMA Dermatology. 2024 Jan 1
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type.
Andrew F Alexis, Jonathan I Silverberg, Zakiya P Rice, Seemal R Desai, Luz Fonacier, Kenji Kabashima, Pinaki Biswas, Ricardo Rojo Cella, Gary L Chan, Mark Levenberg, A...> ;Annals of Allergy, Asthma & Immunology. 2024 Mar 1
1 citations
Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasi...
Jin, J., Cronin, A., Roberts-Toler, C., Yeroushalmi, S., Hadeler, E., Spencer, R., Elhage, K., Gondo, G., Wallace, E., Reddy, S., Han, G., Kaffenberger, J., Davis, M.,...> ;Journal of the American Academy of Dermatology. 2023 Nov 1
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascend...
Karen A Veverka, Steven T G Thng, Jonathan I Silverberg, April W Armstrong, Josemund Menezes, Alexandre Kaoukhov, Andrew Blauvelt> ;Journal of the American Academy of Dermatology. 2024 Mar 1
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.
April W Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor Chirikov> ;Dermatology and Therapy. 2023 Nov 1
2 citations
Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation.
April W Armstrong, Carly A Elston, Boni E Elewski, Laura K Ferris, Alice B Gottlieb, Mark G Lebwohl, , Merola, J. F., Merola, J. F., Merola, J. F.> ;Journal of the American Academy of Dermatology. 2024 Apr 1
Join now to see all

Lectures

Controversies and Difficult Questions Concerning Biologic Therapeutics
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
New Concepts and Emerging Therapies in Metabolic Disorders and Vascular Disease 2012
UC Davis Health System, Monterey, California - 10/6/2012

Other

Pathologic characteristics of melanoma
Armstrong AW, Mihm MC, Liu V
http://www.uptodate.com/contents/pathologic-characteristics-of-melanoma
UpToDate, Wolters Kluwer Health - 2013-01-27
Pathologic evaluation of regional lymph nodes in melanoma
Armstrong AW, Mihm MC, Liu V
http://www.uptodate.com/contents/pathologic-evaluation-of-regional-lymph-nodes-in-melanoma
UpToDate, Wolters Kluwer Health - 2012-08-09
Treatment selection for moderate to severe plaque psoriasis in special populations
Armstrong AW
http://www.uptodate.com/contents/treatment-selection-for-moderate-to-severe-plaque-psoriasis-in-spec
UpToDate, Wolters Kluwer Health - 2013-02-14

Press Mentions

FDA Approves First Once-Daily Oral Plaque Psoriasis DrugSeptember 18th, 2022
How to Spot the Difference Between Chronic and Acute InflammationAugust 30th, 2021

Committees

Chair, Sub-Committee On Teledermatology Outreach, American Telemedicine Association 2009 - 2011
Member, National Psoriasis Foundation Strategic Planning Committee

Research History

Researcher1. investigating epidemiology of comorbid conditions associated with inflammatory skin diseases such as psoriasis 2. evaluating the safe use of systemic medications for chronic inflammatory skin diseases 3. improving health care quality and effectiveness using tech-enabled healthcare delivery models